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involved in nanoinjection, [ 3 ] its biodegradability, [ 11 ] and elevated 
biocompatibility as demonstrated by its safe use for intravenous 
injection, long-term implants, and brachytherapy. [ 12–15 ] Porous 
silicon has a large and spatially constrained interface area for 
biological interaction, [ 16 ] ideally suited for both electrical and 
optical biosensing. [ 17–19 ] 
 Cathepsin B (CTSB) is a cysteine protease usually confi ned to 
the lysosomes and employed as a biomarker in a wide range of 
solid tumors, correlating with increased invasiveness and poor 
prognosis. [ 20,21 ] We designed a nanoneedle sensor to detect the 
cytosolic activity of CTSB, anticipated to be minimal for healthy 
cells where CTSB is confi ned to the lysosomes, and increased for 
cancer cells where CTSB is aberrantly activated in the cytosol. [ 22 ] 
The sensor consisted of a fl uorescently labeled CTSB cleavable 
peptide covalently conjugated to a nanoneedle array ( Figure  1 a). 
Upon interfacing, the nanoneedles in the array interfaced with 
the intracellular environment and were able to sense intracel-
lular activity. The action of CTSB then cleaved the peptide and 
released the fl uorescent label in the cytosol. It was anticipated 
that higher CTSB activity would correspond to higher cytosolic 
fl uorescence and allow mapping of CTSB activity within a cell 
population by fl uorescence micro scopy or fl ow cytometry. 
 Here, we present this nanoneedle biosensor that can map 
the intracellular activity of the cysteine protease CTSB both in 
cell culture and across a large area of bioptic tissue. The sensor 
discriminates CTSB positive (+ve) cancer cells from CTSB 
negative (−ve) cells in a mixed culture. The nanoneedles also 
sense the difference in CTSB activity in tissue resected from 
patients with esophageal cancer. The mapping resolution, 
which approaches the single-cell level, highlights CTSB +ve and 
−ve regions within a single tumor resection specimen. These 
fi ndings highlight a translational potential for nanoneedles as 
a minimally invasive exploratory tool for a more accurate selec-
tion of biopsy sites and for appropriate mapping of target areas 
during endoscopic mucosal resection. 
 The manufacturing of nanoneedles is described in our pre-
vious study, [ 3 ] and combined photolithography with metal 
assisted chemical etching to yield approximately 5 µm tall 
nanoneedles with a 2 µm pitch and a less than 50 nm tip dia-
meter (Figure  1 b). These nanoneedles interact with the intracel-
lular environment (Figure  1 c,d) as we have previously shown. [ 8 ] 
The CFKK peptide, modifi ed at the terminal lysine with the car-
boxytetramethylrhodamine (TAMRA) fl uorescent probe, acted 
as a CTSB-specifi c sensing element. [ 23 ] The liquid phase deposi-
tion of a 3-aminopropyltriethoxysilane (APTES) layer followed 
by that of a heterobifunctional amine to sulfhydryl crosslinker 
covalently conjugated the sensing probe to the porous silicon 
nanoneedles through the sulfhydryl group on the C-terminal 
cysteine. The assembled sensor was able to specifi cally detect 
 Nanoneedles are developing into versatile nanoscale tools for 
cell biology and medical intervention. [ 1 ] Their fabrication draws 
from the experience of vertically aligned nanowires, allowing 
for the development of solid, [ 2 ] hollow or porous [ 3,4 ] structures 
from silicon, [ 5 ] carbon, [ 6 ] and several other semiconductors. [ 7 ] 
Nanoneedles are one of the most sophisticated and minimally 
invasive tools that allow direct access and manipulation of the 
intracellular environment. They can deliver a vast range of bio-
active molecules and nanoparticles to the cytosol, [ 2,3,8 ] as well 
as probe the electrical and the biochemical environment inside 
cells. Metallized silicon nanoneedles can interface in parallel 
to multiple neuronal cells, enabling either intracellular elec-
trical stimulation or recording of the propagation of action 
potentials across a synapse. [ 9 ] Arrays of nanoneedle-based fi eld 
effect transistors enable the recording of the electrical activity 
across a network of cardiomyocytes. [ 5 ] Nanoneedles function-
alized with proton sensitive fl uorescent probes can sense the 
lowered intracellular pH of cultured cancer cells, [ 8 ] whilst func-
tionalization with caspase sensors enables the identifi cation of 
apoptosis induced in cells. [ 10 ] Indeed nanoneedles could be a 
unique tool for large scale mapping of the intracellular environ-
ment, inducing minimal perturbation to the target culture or 
tissue. This capability also enables nanoneedles to compete in 
the development of medically translatable therapeutic and diag-
nostic devices that have a low invasive potential. 
 The recent development of biodegradable porous silicon 
nanoneedles indicates a path for safe and effective use in vivo 
through a demonstrated delivery of multiple payloads, including 
nucleic acids for genetic engineering and neovasculariza-
tion. [ 3,8 ] The suitability of porous silicon as a material for intra-
cellular sensing stems from its ability to withstand the forces 
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CTSB in solution. A dose-dependent and time-dependent 
response resulted from exposing the sensor to CTSB and meas-
uring the fl uorescence released in solution, as expected from 
an assay for enzymatic activity (Figure  1 e). The sensing was 
specifi c to CTSB activity as minimal background signal pre-
sented: (i) in the absence of CTSB, (ii) when 20 × 10 −6  M CA-074 
inhibited 1 U mL −1 CTSB, or (iii) when the sensor was exposed 
to 1U mL −1 of papain, which belongs to the same cysteine pro-
tease family of CTSB. 
 The nanoneedle sensor allowed for mapping of CTSB 
activity within cells. We fi rst selected two esophageal epithelial 
cell lines, HET-1A (CTSB −ve) and OE33 (CTSB +ve) respec-
tively immortalized and transformed (cancerous) as a matched 
pair, which displayed a marked difference in their CTSB activity 
and localization. The cancerous OE33 cells displayed a mark-
edly higher expression of CTSB than HET-1A cells both at the 
RNA level (Figure S1, Supporting Information) and protein 
level ( Figure  2 a). This higher CTSB expression resulted in an 
eightfold higher activity for OE33 cultures as shown by a com-
mercial assay performed on cell lysates (Figure  2 b). CTSB 
presented throughout the cytosol of OE33 cells while it was 
confi ned inside the endolysosomal system for Het-1A cells 
(Figure S2, Supporting Information). The 1.6 × 10 7 nanonee-
dles present on each 70 mg chip were interfaced with the cells 
by centrifugation at 150 rcf, providing a penetration force of 
6.4 nN per needle, which lays within the penetration range 
observed in the literature. [ 24,25 ] When nanoneedles functional-
ized with the CTSB probe were interfaced with single cultures, 
they displayed a higher fl uorescence originating from OE33 
cells compared to Het-1A cells for all exposure times ranging 
from 3 to 60 min (Figure 2c,d). The fl uorescence intensity was 
time-dependent, reaching a maximum at 5 min and then slowly 
declining for both cell types. To insure the signal observed orig-
inated from proteolytic cleavage rather than uptake of adsorbed 
peptide, we employed the  D -isomer of the peptide as a sensing 
element, which is impervious to proteolytic cleavage. Both 
the OE33 and the Het-1A cells interfaced with the  D -isomer 
showed minimal cytosolic fl uorescence, in comparison to that 
observed for the  L -isomer (Figure S3, Supporting Information). 
When employing cytosolic fl uorescence as a classifi er to distin-
guish OE33 from Het-1A cells in isolated cultures, we found a 
receiver operator characteristic (ROC) with an area under the 
curve (AUC) of 1 at all times, indicating a correct classifi cation 
of all OE33 and Het-1A cells analyzed (Figure S4, Supporting 
Information). 
 When we placed the Het-1A and OE33 cells in coculture and 
interfaced with the nanoneedle sensor for 15 min, it was still 
possible to distinguish the higher intracellular fl uorescence of 
CTSB +ve OE33 cells compared to the CTSB −ve Het-1A cells 
by confocal microscopy (Figure  2 e,f). On average, OE33 cells 
displayed a cytosolic fl uorescence 15-fold higher than that of 
Het-1A cells. In this instance, the AUC for the ROC of the classi-
fi er was 0.858 (Figure S4, Supporting Information). Flow cytom-
etry confi rmed the fl uorescence microscopy observations and 
provided an unbiased discrimination between OE33 and Het-1A 
cells through their cytosolic fl uorescence; the AUC was 0.701 
(Figure  2 g, Figure S4, Supporting Information). The lower AUC 
observed by fl ow cytometry likely arose from the inclusion in the 
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 Figure 1.  The nanoneedle Cathepsin B sensor. a) Schematic diagram of sensor functionality when interfacing with cells. Nanoneedles interface the 
cytosol of cells where active CTSB cleaves its CFKK peptide substrate, releasing the linked TAMRA fl uorescent probe in the cell cytosol. Higher CTSB 
activity corresponds to a higher cytosolic fl uorescence. Scanning electron microscopy image of b) a nanoneedle and c) a cell seeded over a nanoneedle 
chip. d) Laser scanning confocal fl uorescent microscopy image (LSC) showing nanoneedles interfacing with cells. Nanoneedles in green, cell mem-
brane in red, nucleus in blue. e) Quantifi cation of fl uorescence released in solution from nanoneedles exposed to different concentrations of CTSB. 
Red lines represent CTSB at the indicated concentration in U/mL. PAP represents papain at 1 U mL –1 , INH represents 1 U mL –1 CTSB inhibited with 
1 10 –6  M CA-074. Negative control is represented by 0. The double entry table reports statistical signifi cance between all pairs.
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 Figure 2.  Sensing CTSB activity in cells in culture. a) Sections of western blot membrane cut at the appropriate molecular weight for pro-
CTSB, CTSB and β-actin showing their expression in HET-1A and OE33 cells with relative band quantifi cation. Sections are outlined in black. 
b) Quantifi cation of CTSB activity in HET-1A and OE33 cells by fl uorogenic homogenous assay in cell lysates. c) Representative LSCs of HET-1A and 
OE33 cells following application of the nanoneedle sensor for 15 min. Single z-plane collected through the cytosol above the level of the nanoneedles. 
Cytosolic fl uorescence originates from cleaved CTSB substrate (yellow). Nuclei stained in blue. d) Quantifi cation of the area-normalized fl uorescence 
cytosolic signal for OE33 (yellow) and HET-1A (blue) cells interfaced with nanoneedles. The horizontal axis represents interfacing time. e) Representa-
tive LSCs of HET-1A and OE33 cells in coculture following application of the nanoneedles sensor for 15 min. Single z-plane collected through the 
cytosol above the level of the nanoneedles. Cytosolic fl uorescence originates from cleaved CTSB substrate. Nuclei stained in blue. Insets show separate 
signal for each fl uorescent channel. OE33 cells are stained in magenta (CellVue). f) Quantifi cation of the area-normalized cytosolic signal for HET-1A 
(blue) and OE33 (yellow) cells interfaced with nanoneedles in coculture. g) Intensity histogram for fl ow cytometric analysis of cytosolic fl uorescence 
for gated HET-1A (blue) and OE33 (yellow) cells interfaced with nanoneedles in coculture. ** p < 0.01, *** p < 0.001.
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analysis of a proportion of cells that did not fully interface with 
the nanoneedles. Those cells could be easily excluded from the 
analysis by confocal microscopy as they fully resided above the 
tips of the nanoneedle array, but could not be discerned by fl ow 
cytometry where they contributed to the low fl uorescence inten-
sity peak observed for both HET-1A and OE33 cells (Figure  2 g). 
 We employed the nanoneedle sensor to map CTSB activity 
within excised tissue samples from esophageal adenocarcinoma 
patients. An 8 × 8 mm array of nanoneedles could sense CTSB 
activity within the cytosol of cells on the surface of tissue directly 
underneath the chip ( Figure  3 ), leaving a clear demarcation line 
between the area beneath the chip and the one outside (Figure  3 a). 
Adv. Mater. 2015, 27, 5147–5152
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 Figure 3.  Sensing of CTSB activity in human esophageal tissue. a) LSCs of a human esophageal epithelium sample interfaced with the CTSB nanoneedle 
sensor for 15 min. The visible demarcation line between fl uorescent and nonfl uorescent cells originates from the edge of the chip. The side view shows 
a steep height profi le within the tissue at the interfacing edge. b) Sections of western blot membrane cut at the appropriate molecular weight for 
pro-CTSB, CTSB and β-actin showing protein expression with quantifi cation for matching normal (N1 and N2) and diseased (Tumour T1, Barrett's 
Dysplasia B2) region of tissues from patient 1 (N1, T1) and patient 2 (N2, B2), respectively. Sections are outlined in black. c) LSCs of the esopha-
geal epithelium normal (N1, N2) and diseased (T1, B2) samples interfaced with the CTSB nanoneedle sensor for 15 min. The yellow fl uorescence 
signal originates from cleaved CTSB substrate. Quantifi cation of the fl uorescent signal for single cells shows statistically higher fl uorescence for 
diseased samples (T1, B2). d) Sections of western blot membrane cut at the appropriate molecular weight for pro-CTSB, CTSB and β-actin showing 
protein expression with quantifi cation for matching normal (N3) and diseased (T3) region of tissues from patient 3. Sections are outlined in black. 
e) Photograph of the margin tissue sample from patient 3 immediately prior to interfacing with nanoneedles. Colored dots identifi ed by letters refer to 
the approximate position of the confocal microscopy images displayed in panels (g–j). f) Quantifi cation of CTSB activity in the different areas of the 
sample is shown in (e): tumor region (T, panels g, h), CTSB +ve region at the visible tumor margin (B+), CTSB -ve region at the visible tumor margin 
(B-) (panels i, j), normal region (N, Figure S6). (g, h) LSCs of the areas indicated in (e): (g, h) within the tumor region (i, j) at the tumor margin. The 
side views show a regular profi le without steep changes in height that could affect interfacing or indicate proximity to the edge of the chip. All LSCs XY 
views are maximum intensity projections along the Z-axis, and all XZ and YZ views are single plane sections. *** p < 0.001.
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By comparison, a fl at chip was unable to detect any CTSB activity 
in the same conditions (Figure S5, Supporting Information). 
 Tissue samples from tumor (T1), the premalignant condi-
tion known as Barrett’s Dysplasia (B2) and matched normal 
proximal mucosa (N1 and N2) were harvested from two freshly 
resected esophagi. The nature of tissues was verifi ed by histo-
pathological examination of immediately adjacent tissue. 
Both patients exhibited a higher CTSB expression in the dis-
eased tissue (T1/B2) compared to the normal tissue (N1/
N2) as quantifi ed by western blot (Figure  3 b). Applying the 
nanoneedle sensor to the tissues for 15 min allowed for the dis-
crimination of normal samples from diseased ones; the latter 
displaying a higher cytosolic fl uorescence (Figure  3 c). The map-
ping defi nition within the tissue approached that of a single cell 
and in many instances allowed for the distinction of cell bound-
aries and consequently the quantifi cation of the individual cell 
fl uorescence within the tissue (Figure  3 c). 
 Esophageal mucosa from a third patient offered an oppor-
tunity to map areas of high and low CTSB activity in the same 
portion of tissue excised from the margin region of the tumor. 
Tissue from this patient displayed an increased CTSB expression 
in the tumor region compared to the healthy region (Figure  3 d). 
Applying the sensor across the portion of tissue including the 
visible tumor margin (Figure  3 e, Figure S6, Supporting Informa-
tion) allowed for the identifi cation of three key regions (Figure 
 3 e–j). Within the tumor, we detected a CTSB +ve area, displaying 
uniformly elevated cytosolic fl uorescence (T, Figure  3 f-h). A 
second area within the visually healthy region of the sample was 
identifi ed as CTSB −ve, showing uniformly low cytosolic fl uo-
rescence (N, Figure 3f, Figure S7, Supporting Information). The 
third region, located in between the CTSB +ve and CTSB −ve 
regions, presented interspersed CTSB +ve (B+) and CTSB −ve 
(B−) areas in close proximity to one another (Figure  3 f,i,j). These 
interspersed CTSB areas did not appear to be artifacts due to 
nanoneedles interfacing, as they differed from the demarcations 
occurring at the edge of the chip, did not follow straight lines, 
and were not associated with sharp slopes on the tissue surface 
at the demarcation (Figure  3 a,i,j). The interspersed CTSB +ve 
and −ve areas will require further analysis of a larger cohort in 
correlation with histopathology in order to determine the value 
of biomarker mapping in detecting tumor margin. 
 This study developed a biosensor based on biodegradable 
nanoneedles capable of mapping intracellular CTSB activity in 
human tissue. The mapping achieved single cell resolution in 
culture and provided a robust strategy to rapidly distinguish cell 
phenotype in mixed culture. Resolution approached that of a 
single cell within tissue and allowed the observation of sharp 
demarcations between adjacent areas with different CTSB 
activity. These fi ndings suggest that nanoneedles can be devel-
oped into a platform in cancer diagnostics that aim at a rapid 
stratifi cation to identify critical areas for an in-depth analysis 
and targeted biopsies. 
 The choice of the esophagus for this proof-of-principle study 
illustrates a potential deployment strategy of CTSB nanoneedles 
for the screening of malignant changes in patients with Bar-
rett’s dysplasia. These patients carry a 30- to 60-fold increased 
risk of developing esophageal adenocarcinoma. [ 26 ] Barrett’s 
patients undergo regular endoscopic surveillance and multiple 
level biopsies to determine disease progression. A nanoneedle 
sensor applied to the esophageal epithelium during endos-
copy could potentially guide the selection of the biopsy sites in 
order to avoid sampling errors and misdiagnosis. Furthermore, 
esophageal cancer may be missed at endoscopy in up to 7.8% 
of patients who are subsequently diagnosed with cancer. [ 27 ] The 
nanoneedle sensor may thus potentially help endoscopists to 
avoid missing subtle early cancers. 
 Combined with our recent assessment of the nanoneedle 
interface [ 8 ] and the development of a nanoneedle device for 
genetic engineering in vivo, [ 3 ] the current study defi nes nanon-
eedles as a unifi ed platform capable of highly localized delivery 
of a wide array of bioactive agents and mapping of the inner 
workings of cells without altering the target tissue. These fi nd-
ings demonstrate the versatility of nanoneedles to mediate the 
interaction within the intracellular space in complex organisms. 
This novel technology holds great promise for highly localized 
in vivo bioengineering at the bedside. 
 Experimental Section 
 Assembly of Nanoneedles Sensor : Nanoneedles were fabricated as 
previously reported. [ 3,4 ] The nanoneedles were fi rst oxidized by O 2 
plasma for 10 min (0.4 mTorr, 75W, Diener plasma asher) and then 
treated with 2% v/v 3-aminopropyltriethoxysilane in ethanol for 2 h, 
and thoroughly washed with ethanol. The samples were incubated for 
2 h with 10 × 10 −6  M 1:4 SMPEG-12:MSPEG12 (thermo pierce, USA) in 
PBS at RT, washed, incubated for 1.5 h with 0.01 mg mL −1 of CFK-lys-
TAMRA peptide (Lifetein, USA) in PBS, washed three times for 15 min in 
PBS, and once in DI water. The sensors were dried under N 2 stream and 
stored at 4 °C for up to a week. 
 Nanoneedles Sensing in Culture : Culture medium was removed from 
the culture in a two-well chamberslide, leaving a thin layer over the 
cells. The nanoneedle chip was placed over the culture and centrifuged 
at 150 rcf for 1 min. Fresh medium was added and the culture was 
incubated for the desired time. LSC imaging was performed on the 
chip following the fi xation of cells with 4% w/v PFA for 15 min. Flow 
cytometry was performed on cells after trypsinisation from the chip and 
fi xation in 1% w/v PFA for 15 min. 
 Nanoneedles Sensing in Tissue : The study employed human tissue 
samples stored by the Imperial College Healthcare Tissue Bank. The study 
was approved by the institutional review board at the Imperial College 
National Healthcare Service Trust (UK Research Ethics Committee 
reference 04/Q0403/119, project reference R12063). The tissue was 
thawed at room temperature and rapidly interfaced with nanoneedles 
applying manual pressure. The interfaced tissue sample was incubated 
for 15 min at 37 °C in a tissue culture incubator, when the chip was 
removed. The tissue was immediately stained with DAPI for 10 min and 
imaged by LSC following immersion into Hanks balanced salt solution. 
 The data presented in Figure 1c,d originate from the same set of 
confocal and SEM experiments previously shown in ref. [ 3 ] . 
 Detailed methods are available in the Supporting Information. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author. 
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